Atlas FDA

VNS THERAPY SYSTEM

FDA premarket approval P970003/S192 · decided 2016-03-23

Approval details

PMA number
P970003
Supplement
S192
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
VNS THERAPY SYSTEM
Generic name
Stimulator, autonomic nerve, implanted for epilepsy
Applicant
LivaNova USA, Inc.
Date received
2016-02-22
Decision date
2016-03-23
Days to decision
30 days
Decision code
OK30
Product code
LYJ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
Removal of a solvent treatment step from the manufacture of Model 302 Leads at the Costa Rica facility.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08